Silverlake Wealth Management LLC Abbott Laboratories Transaction History

Silverlake Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$109.52 - $120.96 $2,628 - $2,903	-24 Reduced 1.23%	1,930 $219 Million
Q4 2023 Jan 22, 2024	BUY	$90.19 - $110.4 $176,231 - $215,721	1,954 New	1,954 $215 Million
Q4 2022 Feb 15, 2023	BUY	$95.06 - $111.52 $176,906 - $207,538	1,861 New	1,861 $204 Million
Q1 2022 Apr 06, 2023	SELL	$114.02 - $139.04 $189,501 - $231,084	-1,662 Closed	0 $0
Q4 2021 Apr 06, 2023	SELL	$115.53 - $141.46 $22,990 - $28,150	-199 Reduced 10.69%	1,662 $234 Million

3,137

1.33B

8.63M

7.17M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Silverlake Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Silverlake Wealth Management LLC with notifications on news.